NFKB1 and neoplasm: IL-10 could inhibit excessive activation of TLR3, and the mechanism of IL-10 involves downregulation of NF-κB pathway, which alleviated inflammatory response in tumor microenvironment (Kanmani and Kim, 2019; Hu et al., 2016; Zhao et al., 2023).